SB-431542

N/A

Report date: 2025/03/18 15:41:09

NME

Base Information

Drug NameSB-431542

Drug Alias NameSB-431542

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTransforming growth factor beta receptor 1 antagonistsActivin receptor type-1C inhibitorsActivin receptor-like kinase 4 inhibitors

TargetsTransforming growth factor beta receptor 1Activin receptor type-1CActivin receptor-like kinase 4

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A